Literature DB >> 16695342

CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). V. SKIN SENSITIZATION TO BAL.

M B Sulzberger1, R L Baer, A Kanof.   

Abstract

Entities:  

Year:  1946        PMID： 16695342      PMCID： PMC435588          DOI： 10.1172/JCI101732

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  2 in total

1.  BAL (BRITISH ANTI-LEWISITE).

Authors:  L L Waters; C Stock
Journal:  Science       Date:  1945-12-14       Impact factor: 47.728

2.  CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). III. STUDIES ON THE TOXICITY OF BAL ON PERCUTANEOUS AND PARENTERAL ADMINISTRATION.

Authors:  M B Sulzberger; R L Baer; A Kanof
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808
  2 in total
  2 in total

1.  CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). III. STUDIES ON THE TOXICITY OF BAL ON PERCUTANEOUS AND PARENTERAL ADMINISTRATION.

Authors:  M B Sulzberger; R L Baer; A Kanof
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808

2.  Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of complications of arseno-therapy with BAL (British anti-lewisite).

Authors:  A B CARLETON; R A PETERS
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.